All
My Traumas Associated With Follicular Lymphoma
I’ve heard that trauma doesn’t make people stronger, and I’ve found that after cancer, I’m not the same person that I was before.
‘Full House’ Star Dave Coulier Has Non-Hodgkin Lymphoma
The actor, 65, received his diagnosis of stage 3 non-Hodgkin lymphoma in October, he said.
TIL Therapy Uses the Body’s Own Cells to Attack Cancer Cells in Melanoma
An expert explained how a patient’s own T cells can be extracted, manufactured and infused back into the body as a treatment option for melanoma.
THIO Plus Libtayo May Be Effective in NSCLC
The combination of THIO and Libtayo has shown promising results among patients with advanced checkpoint inhibitor-resistant non-small cell lung cancer.
QOL a Crucial Consideration During R/R Myeloma Treatment Decision-Making
Patients with relapsed or refractory multiple myeloma should consider quality of life with survival when choosing the most suitable treatment option.
My Mammogram Prayers After Breast Cancer
Having a collection of prayers before, during and after a mammogram has helped ease my mind tremendously after having breast cancer.
3 Cycles of Chemo as Beneficial as 6 in Pediatric Retinoblastoma
Three cycles of chemotherapy were found to face similar results as six cycles among children with retinoblastoma, a type of cancer of the eye.
Facing the Challenges of Late-Stage Ovarian Cancer: Navigating Limited Treatment Options and Advocating for New Therapies
Managing Trodelvy’s Side Effects Through Dose Adjustment
An expert told CURE that Trodelvy's side effects, such as neutropenia and fatigue, can often be managed through dose adjustments.
Tracking Side Effects May Help Patients With Breast Cancer Communicate Concerns
In this on-demand webinar series, CURE partnered with UCLA Health and Northside Hospital Cancer Institute to discuss best approaches to tracking side effects for patients with breast cancer.
Understanding Common Side Effects of Breast Cancer Treatment
In this on-demand webinar series, CURE partnered with UCLA Health and Northside Hospital Cancer Institute to discuss side effects of breast cancer treatment.
Mitigating Side Effects During Breast Cancer Treatment
CURE partnered with UCLA Health and Northside Hospital Cancer Institute for an on-demand webinar series on managing side effects of breast cancer treatment.
Circulating Tumor Cells May Predict Prostate Cancer Survival
Researchers have found an association between baseline circulating tumor cell count and survival in metastatic hormone-sensitive prostate cancer.
My Friend’s Cancer Diagnosis Made Me Reflect on My Own
When a dear friend told me he has lung cancer, I opened up and shared my own perspective and experience as a survivor of testicular cancer.
Ponsegromab May Aid Weight Gain in Patients With Cachexia
Ponsegromab helped patients with cachexia and elevated GDF-15 levels gain weight, increase activity and improve cachexia symptoms, with manageable safety.
FDA Receives Application Seeking Approval of Darzalex Faspro in Smoldering Myeloma
If approved by the FDA, Darzalex Faspro may be the first treatment for smoldering multiple myeloma as compared to treating the disease once it progresses.
Compassionate and Expert Care of Patients With Cancer
Susan K. Bohnenkamp, an oncology clinical nurse specialist, is recognized for her compassionate and expert care, going above and beyond to support her patients through their cancer journey.
The Decision to Irradiate or Not to Irradiate My Daughter’s Brain Tumor
My daughter's diagnosis of a rare and aggressive brain tumor at 3 years old made me strongly consider whether or not to have her treated with radiation.
FDA Approves MI Cancer Seek as Companion Diagnostic for Adult and Pediatric Patients With Cancer
MI Cancer Seek has received approval from the FDA as a companion diagnostic test to identify those who may benefit from treatment with targeted therapies.
FDA Approves CAR-T Cell Therapy for Relapsed or Refractory B-Cell ALL
The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based on findings from the FELIX trial.
GVHD Prophylaxis Using PTCY Remains Valid Treatment Option in MDS
Graft-versus-host disease prophylaxis using posttransplant cyclophosphamide remains a valid option for patients with myelodysplastic syndromes.
Rest and Recuperation After a Cancer Diagnosis and Treatment
After cancer treatment, I wanted to go right back to living my life normally, but a fellow CURE blogger’s post reminded me that rest is necessary too.
James Van Der Beek Opens Up About Colorectal Cancer, U.S. Congressman Reveals Cancer Diagnosis and More
From James Van Der Beek spreading awareness about colorectal cancer at a younger age to Gerry Connolly’s recent esophageal cancer diagnosis, here’s what’s happening in the cancer space this week.
Bavencio Combo May Show Efficacy, Safety in Advanced Leiomyosarcoma
The combination of Bavencio and gemcitabine showed promising efficacy and safety in certain patients with advanced leiomyosarcoma.
Improving Quality of Life During Breast Cancer Through Care Team Discussions
CURE partnered with City of Hope for a webinar to discuss focusing on quality of life when talking with care teams during breast cancer treatment.
Communicating With the Care Team During Breast Cancer Treatment
In this on-demand webinar series, CURE partnered with City of Hope to discuss how patients with breast cancer can best communicate with their care team.
Navigating Breast Cancer Treatment Options With Effective Care Team Communication
In this on-demand webinar series, CURE partnered with City of Hope to discuss effective communication when making treatment decisions for breast cancer.
James Van Der Beek Has Colorectal Cancer, a Disease on the Rise in Younger Adults
Rates of colorectal cancer diagnoses and deaths are climbing among patients younger than 55, researchers have shown.
The Pathway of Cancer is Fraught with Anxiety
As a patient with chronic lymphocytic leukemia, I recently gleaned three new insights from my oncologist and phlebotomist.
KRd56 Versus KRd27 Shows Similar Effectiveness, Safety in R/R Multiple Myeloma
In patients with relapsed or refractory multiple myeloma, KRd56 and KRd27 showed similar effectiveness and safety, but other treatment options may be better.
